本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inozyme Pharma

0.9740
+0.01401.46%
成交量:13.46万
成交额:12.86万
市值:6,257.00万
市盈率:-0.60
高:0.9771
开:0.9600
低:0.9402
收:0.9600
数据加载中...
2021/05/12

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/07

重要事件披露

8-K - Current report
2021/04/21

重要事件披露

8-K - Current report
2021/03/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/03

重要事件披露

8-K - Current report
2020/08/07

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership